BG names new CEO, boosts sales for diagnostic test

05/13/2013 | Clinica (subscription required)

Paul Sohmer, who most recently led Viracor-IBT Laboratories, has been appointed to replace Eric Bouvier as president and CEO of BG Medicine. The Waltham, Mass.-based cardiovascular diagnostics firm also posted $0.8 million in sales from its BGM Galectin-3 assay during its fiscal first quarter, a rise from $0.4 million in the same period last year.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN